Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in INO held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 9.3M | $16.3M | -5.1% | 1.352% | 0.00% |
| 2 | JANUS HENDERSON GROUP PLC | 3.3M | $5.8M | 0.0% | 0.479% | 0.00% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 2.9M | $5.0M | β | 0.420% | 0.00% |
| 4 | Boxer Capital Management, LLC | 2.4M | $4.1M | -2.1% | 0.343% | 0.54% |
| 5 | D. E. Shaw & Co., Inc. | 2.2M | $3.9M | -0.9% | 0.320% | 0.00% |
| 6 | ADAR1 Capital Management, LLC | 1.5M | $2.6M | -5.8% | 0.213% | 0.16% |
| 7 | MILLENNIUM MANAGEMENT LLC | 1.4M | $2.5M | +0.5% | 0.204% | 0.00% |
| 8 | Eversept Partners, LP | 1.0M | $1.8M | β | 0.150% | 0.12% |
| 9 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 805K | $1.4M | -68.5% | 0.117% | 0.00% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 802K | $1.4M | +4.2% | 0.116% | 0.00% |
| 11 | BlackRock, Inc. | 662K | $1.2M | +7.2% | 0.096% | 0.00% |
| 12 | RENAISSANCE TECHNOLOGIES LLC | 644K | $1.1M | +16.4% | 0.093% | 0.00% |
| 13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 461K | $802K | +26.9% | 0.067% | 0.00% |
| 14 | VANGUARD FIDUCIARY TRUST CO | 392K | $682K | β | 0.057% | 0.00% |
| 15 | TWO SIGMA INVESTMENTS, LP | 390K | $679K | +21.0% | 0.056% | 0.00% |
| 16 | NORTHERN TRUST CORP | 299K | $520K | -0.4% | 0.043% | 0.00% |
| 17 | STATE STREET CORP | 296K | $516K | +19.8% | 0.043% | 0.00% |
| 18 | UBS Group AG | 250K | $434K | +46.4% | 0.036% | 0.00% |
| 19 | 683 Capital Management, LLC | 249K | $433K | 0.0% | 0.036% | 0.03% |
| 20 | XTX Topco Ltd | 213K | $370K | +27.3% | 0.031% | 0.01% |
| 21 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 173K | $301K | 0.0% | 0.025% | 0.01% |
| 22 | GMT CAPITAL CORP | 126K | $219K | β | 0.018% | 0.01% |
| 23 | Green Alpha Advisors, LLC | 66K | $114K | -9.0% | 0.009% | 0.11% |
| 24 | MORGAN STANLEY | 64K | $111K | -39.6% | 0.009% | 0.00% |
| 25 | Tower Research Capital LLC (TRC) | 55K | $97K | β | 0.008% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in INO β a direct measure of their conviction.
Filings activity in INO during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 95 | 5.0% | 6.97% | 0.53 pp | $53M | 7.1% |
| Q4 2025 | 100 | +3.1% | 7.50% | +1.22 pp | $57M | +20% |
| Q3 2025 | 97 | 6.7% | 6.28% | +3.58 pp | $48M | +133% |
| Q2 2025 | 104 | 4.6% | 2.70% | 0.19 pp | $21M | 6.4% |
| Q1 2025 | 109 | +4.8% | 2.89% | 0.33 pp | $22M | 10% |
| Q4 2024 | 104 | +6.1% | 3.22% | 3.47 pp | $24M | 52% |
| Q3 2024 | 98 | +3.2% | 6.69% | 1.88 pp | $51M | 22% |
| Q2 2024 | 95 | β | 8.57% | β | $65M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying INO stock.
Based on Q1 2026 13F filings, institutional ownership of Inovio Pharmaceuticals, Inc. stands at 7.0%, held across 95 reporting institutions.
FMR LLC is the largest reported institutional holder of INO, with approximately 9,339,614 shares worth $0.02B as of Q1 2026.
Yes β 4 widely-followed marquee investors appear among the top 25 institutional holders of INO, including MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA INVESTMENTS, LP.
Our composite Smart Money Score for INO is 50 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
18 institutions opened new positions in INO during Q1 2026, while 23 fully exited. 18 added to existing positions and 22 trimmed.
INO institutional ownership fell by 0.53 percentage points quarter-over-quarter, with a net change of -5 holders.
The top 10 institutions account for 84.3% of all reported 13F value in INO, and the top 25 account for 98.6%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Inovio Pharmaceuticals, Inc. (INO) Institutional Ownership